-
公开(公告)号:US12103916B2
公开(公告)日:2024-10-01
申请号:US15836675
申请日:2017-12-08
IPC分类号: C07D249/08 , A01N33/08 , A01N43/60 , A01N43/653 , A01N43/84 , A01N47/12 , A61P31/10 , C07C217/08 , C07C271/16 , C07D295/03 , C07D403/06 , C07D405/06
CPC分类号: C07D249/08 , A01N33/08 , A01N43/60 , A01N43/653 , A01N43/84 , A01N47/12 , A61P31/10 , C07C217/08 , C07C271/16 , C07D295/03 , C07D403/06 , C07D405/06
摘要: Compounds and compositions having antifungal activity, and methods of using the antifungal compounds and compositions, are described for use in treating fungal infections.
-
公开(公告)号:US11517528B2
公开(公告)日:2022-12-06
申请号:US16622109
申请日:2018-06-15
发明人: Hideyoshi Harashima , Yusuke Sato
IPC分类号: A61K31/713 , C07D211/32 , A61K9/127 , C07D295/03
摘要: A lipid membrane structure includes, as lipid components, a lipid compound represented by Formula (I): (R1)(R2)C(OH)—(CH3)a—(O—CO)b—X (I) [in the formula, a represents an integer of 3 to 5; b represents an integer of 0 or 1; R1 and R2 each independently represents a linear hydrocarbon group that may have —CO—O—; and X represents a 5- to 7-membered non-aromatic heterocyclic group or a group represented by Formula (B) (in the formula, d represents an integer of 0 to 3, and R3 and R4 each independently represents a C1-4 alkyl group or a C2-4 alkenyl group, where, R3 and R4 may be bonded to each other to form a 5- to 7-membered non-aromatic heterocycle (where, one or two C1-4 alkyl groups or C2-4 alkenyl groups may be substituted on the ring)].
-
公开(公告)号:US11434206B2
公开(公告)日:2022-09-06
申请号:US16984467
申请日:2020-08-04
申请人: HONOUR (R&D)
发明人: Bandi Parthasaradhi Reddy , Kura Rathnakar Reddy , Bandi Vamsi Krishna , Kesireddy Subhash Chander Reddy , Kancharla Rajendar Reddy
IPC分类号: C07D241/20 , C07C211/06 , A61K31/495 , C07C211/05 , C07C211/07 , C07C211/08 , A61K31/4965 , C07D295/03
摘要: The present invention relates to a process for the preparation of amorphous Selexipag from Selexipag crystalline salts using a solvent.
-
公开(公告)号:US11299559B2
公开(公告)日:2022-04-12
申请号:US16754600
申请日:2018-11-30
申请人: LG Chem, Ltd.
发明人: Ho Young Lee , Jae Hoon Choe , Kyung Chang Seo , No Ma Kim
IPC分类号: C08C19/28 , C07C211/27 , C07D295/03 , C07D295/033 , C08F236/10 , C08K3/36 , B60C1/00
摘要: A modified conjugated diene-based polymer and a rubber composition including a modified conjugated diene-based polymer are disclosed herein. In some embodiments, a modified conjugated diene-based polymer includes a functional group derived from a modification initiator at one terminal and a functional group derived from a modifier represented by the Formula 2 or Formula 3 at the other terminal, wherein the modified conjugated diene-based polymer having a unimodal molecular weight distribution, and a polydispersity index of 1.0 to less than 1.7. The modified conjugated diene-based polymer prepared by continuous polymerization and having remarkable processability, narrow molecular weight distribution and excellent physical properties.
-
公开(公告)号:US11078171B2
公开(公告)日:2021-08-03
申请号:US16872114
申请日:2020-05-11
IPC分类号: C07D295/03
摘要: Compounds that inhibit p38α MAPK protein, and methods of using the same, are provided for treating or preventing diseases such as cancer or inflammatory diseases.
-
公开(公告)号:US10982337B2
公开(公告)日:2021-04-20
申请号:US15769460
申请日:2016-10-17
IPC分类号: C23F11/04 , C09K8/54 , C07D209/08 , C07D209/14 , C07D215/06 , C07D215/08 , C07D295/03
摘要: A corrosion inhibiting compound with a general structure A-B or A-X-B for inhibition of corrosion of steel in acidic solution. A comprises a heterocyclic ring system having a plurality of cyclic Carbon atoms and at least one cyclic Nitrogen atom, wherein the at least one cyclic Nitrogen atom is neutral under neutral conditions and protonatable under acidic conditions. B comprises at least two unsaturated Carbon atoms. B may comprise a ring system or a polymerisable group.
-
公开(公告)号:US10144700B2
公开(公告)日:2018-12-04
申请号:US15920654
申请日:2018-03-14
发明人: Mingji Dai , Val J. Watts , Zhishi Ye
IPC分类号: C07C211/28 , C07D209/14 , C07C229/34 , C07C229/38 , C07C211/30 , C07C217/62 , C07C211/45 , C07D295/03 , C07C211/27 , C07C215/34 , C07D471/04 , C07C239/20 , C07C211/55 , C07C311/16 , C07D223/16 , C07C229/14 , C07C233/05
摘要: The invention generally relates to adenylyl cyclase inhibitor compounds and methods for treating neuropathic or inflammatory pain by using those compounds.
-
公开(公告)号:US20170226072A1
公开(公告)日:2017-08-10
申请号:US15494789
申请日:2017-04-24
IPC分类号: C07D295/096 , C07D295/073 , C07D211/22 , C07D211/18 , C07D211/14 , C07D295/03
CPC分类号: C07D295/096 , C07D211/08 , C07D211/14 , C07D211/18 , C07D211/22 , C07D295/02 , C07D295/03 , C07D295/073
摘要: The present invention is directed to 1,4-disubstituted piperidines, 1,4-disubstituted piperazines, 1,4-disubstituted diazepanes, and 1,3-disubstituted pyrrolidine compounds and their use.
-
9.
公开(公告)号:US09624232B2
公开(公告)日:2017-04-18
申请号:US14827104
申请日:2015-08-14
申请人: Rhodes Technologies
发明人: Joshua Robert Giguere , Keith Edward McCarthy , Helge Alfred Reisch , Sergio Sandoval , Jake Larry Stymiest
IPC分类号: C07D471/00 , C07D489/08 , B01J31/24 , B01J31/18 , B01J31/22 , B01J31/20 , B01J23/42 , B01J23/44 , C07D295/03 , C07D295/205 , C07C209/00 , C07C269/04 , C07D265/30 , C07C209/44
CPC分类号: C07D489/08 , B01J23/42 , B01J23/44 , B01J31/1855 , B01J31/20 , B01J31/2295 , B01J31/2414 , B01J2231/40 , B01J2531/64 , B01J2531/821 , B01J2531/824 , B01J2531/828 , B01J2531/847 , C07C209/00 , C07C209/44 , C07C269/04 , C07D265/30 , C07D295/03 , C07D295/205 , Y02P20/55 , C07C211/21 , C07C271/12
摘要: The present disclosure provides processes for the N-dealkylation of tertiary amines and the use of transition metal catalysts to prepare tertiary N-allyl amine derivatives and secondary amine derivatives thereof. The tertiary amines can be alkaloids and, more particularly, the tertiary amines can be opioids. In specific embodiments, the present disclosure provides methods for use in processes for the synthesis of naloxone and naltrexone from oripavine.
-
公开(公告)号:US09549983B2
公开(公告)日:2017-01-24
申请号:US14255637
申请日:2014-04-17
IPC分类号: A61K47/18 , A61K31/713 , A61K47/22 , C12N15/113 , A61K9/127 , C12N15/11 , C12N15/88 , C07D233/61 , C07D233/64 , C07D239/42 , C07D241/04 , C07C237/06 , C07D295/03 , C07D211/36 , C07D295/13 , C07D295/15 , C07C211/21 , A61K38/00
CPC分类号: C07D403/06 , A61K9/107 , A61K9/127 , A61K9/1272 , A61K9/145 , A61K9/146 , A61K31/713 , A61K38/00 , A61K47/18 , A61K47/22 , C07C211/21 , C07C237/06 , C07D211/36 , C07D233/61 , C07D233/64 , C07D239/42 , C07D241/04 , C07D243/08 , C07D295/03 , C07D295/13 , C07D295/15 , C07D401/04 , C07D403/04 , C12N15/111 , C12N15/1137 , C12N15/88 , C12N2310/14 , C12N2310/321 , C12N2320/32 , C12Y204/02008
摘要: The present invention relates to lipid compounds and uses thereof. In particular, the compounds include a class of cationic lipids having an amine moiety, such as an amino-amine or an amino-amide moiety. The lipid compounds are useful for in vivo or in vitro delivery of one or more agents (e.g., a polyanionic payload or an antisense payload, such as an RNAi agent).
摘要翻译: 本发明涉及脂质化合物及其用途。 特别地,化合物包括具有胺部分的一类阳离子脂质,例如氨基胺或氨基 - 酰胺部分。 脂质化合物可用于体内或体外递送一种或多种试剂(例如聚阴离子载体或反义载体,例如RNAi试剂)。
-
-
-
-
-
-
-
-
-